NCT05324384 2024-01-24
Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma
West China Hospital
Phase 2 Unknown
Clinical Trials
5 trialsNCT04448873 2023-09-26
Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma
Children's Hospital of Fudan University
Phase 4 Completed
NCT02110069 2023-09-21
A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Boston Children's Hospital
Phase 2 Terminated
NCT04077515 2023-01-30
Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
Children's Hospital of Fudan University
Phase 4 Completed
NCT03188068 2022-04-21
Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma
West China Hospital
Phase 2 Completed